Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 221 of 221 entries
Sorted by: Best Match Show Resources per page
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.

medRxiv : the preprint server for health sciences

Sagara I, Woodford J, Kone M, Assadou MH, Katile A, Attaher O, Zeguime A, Doucoure M, Higbee E, Lane J, Doritchamou J, Zaidi I, Esposito D, Kwan J, Sadtler K, Dicko A, Duffy P.
PMID: 33948607
medRxiv. 2021 Apr 29; doi: 10.1101/2021.04.26.21256016.

BACKGROUND: The extent of SARS-CoV-2 exposure and transmission in Mali and the surrounding region is not well understood, although infection has been confirmed in nearly 14,000 symptomatic individuals and their contacts since the first case in March 2020. We...

Cite
Sagara I, Woodford J, Kone M, et al. Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. medRxiv. 2021;doi: 10.1101/2021.04.26.21256016.
Sagara, I., Woodford, J., Kone, M., Assadou, M. H., Katile, A., Attaher, O., Zeguime, A., Doucoure, M., Higbee, E., Lane, J., Doritchamou, J., Zaidi, I., Esposito, D., Kwan, J., Sadtler, K., Dicko, A., & Duffy, P. (2021). Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.04.26.21256016
Sagara, Issaka, et al. "Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.04.26.21256016
Sagara I, Woodford J, Kone M, Assadou MH, Katile A, Attaher O, Zeguime A, Doucoure M, Higbee E, Lane J, Doritchamou J, Zaidi I, Esposito D, Kwan J, Sadtler K, Dicko A, Duffy P. Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. medRxiv. 2021 Apr 29; doi: 10.1101/2021.04.26.21256016. PMID: 33948607; PMCID: PMC8095226.
Copy Download .nbib Format: NLM
ecDNA hubs drive cooperative intermolecular oncogene expression.

Nature

Hung KL, Yost KE, Xie L, Shi Q, Helmsauer K, Luebeck J, Schöpflin R, Lange JT, Chamorro González R, Weiser NE, Chen C, Valieva ME, Wong IT, Wu S, Dehkordi SR, Duffy CV, Kraft K, Tang J, Belk JA, Rose JC, Corces MR, Granja JM, Li R, Rajkumar U, Friedlein J, Bagchi A, Satpathy AT, Tjian R, Mundlos S, Bafna V, Henssen AG, Mischel PS, Liu Z, Chang HY.
PMID: 34819668
Nature. 2021 Nov 24; doi: 10.1038/s41586-021-04116-8. Epub 2021 Nov 24.

Extrachromosomal DNA (ecDNA) is prevalent in human cancers and mediates high expression of oncogenes through gene amplification and altered gene regulation

Cite
Hung KL, Yost KE, Xie L, et al. ecDNA hubs drive cooperative intermolecular oncogene expression. Nature. 2021;doi: 10.1038/s41586-021-04116-8.
Hung, K. L., Yost, K. E., Xie, L., Shi, Q., Helmsauer, K., Luebeck, J., Schöpflin, R., Lange, J. T., Chamorro González, R., Weiser, N. E., Chen, C., Valieva, M. E., Wong, I. T., Wu, S., Dehkordi, S. R., Duffy, C. V., Kraft, K., Tang, J., Belk, J. A., Rose, J. C., Corces, M. R., Granja, J. M., Li, R., Rajkumar, U., Friedlein, J., Bagchi, A., Satpathy, A. T., Tjian, R., Mundlos, S., Bafna, V., Henssen, A. G., Mischel, P. S., Liu, Z., & Chang, H. Y. (2021). ecDNA hubs drive cooperative intermolecular oncogene expression. Nature, . https://doi.org/10.1038/s41586-021-04116-8
Hung, King L, et al. "ecDNA hubs drive cooperative intermolecular oncogene expression." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-021-04116-8
Hung KL, Yost KE, Xie L, Shi Q, Helmsauer K, Luebeck J, Schöpflin R, Lange JT, Chamorro González R, Weiser NE, Chen C, Valieva ME, Wong IT, Wu S, Dehkordi SR, Duffy CV, Kraft K, Tang J, Belk JA, Rose JC, Corces MR, Granja JM, Li R, Rajkumar U, Friedlein J, Bagchi A, Satpathy AT, Tjian R, Mundlos S, Bafna V, Henssen AG, Mischel PS, Liu Z, Chang HY. ecDNA hubs drive cooperative intermolecular oncogene expression. Nature. 2021 Nov 24; doi: 10.1038/s41586-021-04116-8. Epub 2021 Nov 24. PMID: 34819668.
Copy Download .nbib Format: NLM
Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali.

The Journal of infectious diseases

Woodford J, Sagara I, Dicko A, Zeguime A, Doucoure M, Kwan J, Zaidi I, Doritchamou J, Snow-Smith M, Alani N, Renn J, Kosik I, Holly J, Yewdell J, Esposito D, Sadtler K, Duffy P.
PMID: 34612499
J Infect Dis. 2021 Dec 15;224(12):2001-2009. doi: 10.1093/infdis/jiab498.

BACKGROUND: False positivity may hinder the utility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests in sub-Saharan Africa.METHODS: From 312 Malian samples collected before 2020, we measured antibodies to the commonly tested SARS-CoV-2 antigens and 4 other...

Cite
Woodford J, Sagara I, Dicko A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali. J Infect Dis. 2021;224(12):2001-2009doi: 10.1093/infdis/jiab498.
Woodford, J., Sagara, I., Dicko, A., Zeguime, A., Doucoure, M., Kwan, J., Zaidi, I., Doritchamou, J., Snow-Smith, M., Alani, N., Renn, J., Kosik, I., Holly, J., Yewdell, J., Esposito, D., Sadtler, K., & Duffy, P. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali. The Journal of infectious diseases, 224(12), 2001-2009. https://doi.org/10.1093/infdis/jiab498
Woodford, John, et al. "Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali." The Journal of infectious diseases vol. 224,12 (2021): 2001-2009. doi: https://doi.org/10.1093/infdis/jiab498
Woodford J, Sagara I, Dicko A, Zeguime A, Doucoure M, Kwan J, Zaidi I, Doritchamou J, Snow-Smith M, Alani N, Renn J, Kosik I, Holly J, Yewdell J, Esposito D, Sadtler K, Duffy P. Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali. J Infect Dis. 2021 Dec 15;224(12):2001-2009. doi: 10.1093/infdis/jiab498. PMID: 34612499; PMCID: PMC8522418.
Copy Download .nbib Format: NLM
Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles.

Biomedicines

Chabria Y, Duffy GP, Lowery AJ, Dwyer RM.
PMID: 34829923
Biomedicines. 2021 Nov 15;9(11). doi: 10.3390/biomedicines9111694.

Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid...

Cite
Chabria Y, Duffy GP, Lowery AJ, et al. Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles. Biomedicines. 2021;9(11)doi: 10.3390/biomedicines9111694.
Chabria, Y., Duffy, G. P., Lowery, A. J., & Dwyer, R. M. (2021). Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles. Biomedicines, 9(11), . https://doi.org/10.3390/biomedicines9111694
Chabria, Yashna, et al. "Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles." Biomedicines vol. 9,11 (2021). doi: https://doi.org/10.3390/biomedicines9111694
Chabria Y, Duffy GP, Lowery AJ, Dwyer RM. Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles. Biomedicines. 2021 Nov 15;9(11). doi: 10.3390/biomedicines9111694. PMID: 34829923; PMCID: PMC8615452.
Copy Download .nbib Format: NLM
Metastatic medullary thyroid carcinoma presenting as ectopic Cushing's syndrome.

Endocrinology, diabetes & metabolism case reports

Forde HE, Mehigan-Farrelly N, Ryan K, Moran T, Greally M, Duffy AG, Byrne MM.
PMID: 33899746
Endocrinol Diabetes Metab Case Rep. 2021 Apr 01;2021. doi: 10.1530/EDM-20-0207. Epub 2021 Apr 01.

SUMMARY: A 41-year-old male presented to the Emergency Department with a 6-month history of back and hip pain. Skeletal survey revealed bilateral pubic rami fractures and MRI of the spine demonstrated multiple thoracic and lumbar fractures. Secondary work up...

Cite
Forde HE, Mehigan-Farrelly N, Ryan K, et al. Metastatic medullary thyroid carcinoma presenting as ectopic Cushing's syndrome. Endocrinol Diabetes Metab Case Rep. 2021;2021doi: 10.1530/EDM-20-0207.
Forde, H. E., Mehigan-Farrelly, N., Ryan, K., Moran, T., Greally, M., Duffy, A. G., & Byrne, M. M. (2021). Metastatic medullary thyroid carcinoma presenting as ectopic Cushing's syndrome. Endocrinology, diabetes & metabolism case reports, 2021. https://doi.org/10.1530/EDM-20-0207
Forde, Hannah E, et al. "Metastatic medullary thyroid carcinoma presenting as ectopic Cushing's syndrome." Endocrinology, diabetes & metabolism case reports vol. 2021 (2021). doi: https://doi.org/10.1530/EDM-20-0207
Forde HE, Mehigan-Farrelly N, Ryan K, Moran T, Greally M, Duffy AG, Byrne MM. Metastatic medullary thyroid carcinoma presenting as ectopic Cushing's syndrome. Endocrinol Diabetes Metab Case Rep. 2021 Apr 01;2021. doi: 10.1530/EDM-20-0207. Epub 2021 Apr 01. PMID: 33899746; PMCID: PMC8115413.
Copy Download .nbib Format: NLM
Showing 217 to 221 of 221 entries